# Lornoxicam Versus Etoricoxib in Postoperative Pain After Total Knee Arthroplasty

> **NCT02750917** · PHASE3 · COMPLETED · sponsor: **Foisor Orthopedics Clinical Hospital** · enrollment: 120 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Lornoxicam
- **DRUG:** Etoricoxib

## Key facts

- **NCT ID:** NCT02750917
- **Lead sponsor:** Foisor Orthopedics Clinical Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-03
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02750917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02750917, "Lornoxicam Versus Etoricoxib in Postoperative Pain After Total Knee Arthroplasty". Retrieved via MORVS 2026-10-28 from https://api.morvs.ai/clinical/NCT02750917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*